Effect of high-dose intravenous vitamin C on inflammation in cancer patients.

The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life. Front Oncol (2014) 1.01

Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem (2013) 0.98

Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer (2016) 0.93

Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist (2015) 0.90

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med (2013) 0.90

Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit (2014) 0.85

EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE. Rev Inst Med Trop Sao Paulo (2015) 0.78

Preclinical evaluation of injectable reduced hydroxocobalamin as an antidote to acute carbon monoxide poisoning. J Trauma Acute Care Surg (2015) 0.77

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy. Med Sci Monit (2016) 0.77

Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells. Front Pharmacol (2017) 0.75

The role of vitamin C in the treatment of pain: new insights. J Transl Med (2017) 0.75

High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report. Am J Case Rep (2016) 0.75

Acute ascorbic acid infusion increases left ventricular diastolic function in postmenopausal women. Maturitas (2016) 0.75

High Dose Intraveneous Vitamin C and Chikungunya Fever: A Case Report. J Orthomol Med (2015) 0.75

CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomed Rep (2016) 0.75

Extraocular myositis in a female puppy. Open Vet J (2015) 0.75

Inflammation and cancer. Nature (2002) 53.78

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med (2003) 16.62

Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76

Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75

Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57

Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06

Radical causes of cancer. Nat Rev Cancer (2003) 5.45

Inflammation, a key event in cancer development. Mol Cancer Res (2006) 5.03

C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94

Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A (1976) 4.89

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol (2010) 4.83

Inflammation and cancer: an ancient link with novel potentials. Int J Cancer (2007) 4.19

IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A (2003) 3.80

Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care (2009) 3.57

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A (2005) 3.30

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol (2009) 3.23

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer (2006) 3.19

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res (2009) 2.98

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest (1993) 2.92

Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia (2002) 2.90

Chemokines and cancer. Int J Cancer (2006) 2.75

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res (2007) 2.71

The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep (2002) 2.47

The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia (2002) 2.37

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer (2006) 2.33

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol (2008) 2.27

Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol (2003) 2.17

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol (2004) 2.11

Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis (2002) 2.08

The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer (2005) 2.05

Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol (2004) 1.96

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95

C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM (2003) 1.93

Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg (2006) 1.93

Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92

C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem (2007) 1.79

Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 1.78

Regulation of complement activation by C-reactive protein. Immunopharmacology (1999) 1.78

Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol (2003) 1.65

Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res (2008) 1.64

Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol (2001) 1.59

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene (2004) 1.54

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48

Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol (1979) 1.44

Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol (2002) 1.40

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses (1995) 1.36

Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev (2006) 1.34

Inflammatory disease processes and interactions with nutrition. Br J Nutr (2009) 1.34

Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res (2001) 1.32

Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry (2002) 1.30

Inflammation and cancer: causes and consequences. Clin Pharmacol Ther (2010) 1.27

Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol (2000) 1.26

Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer (2006) 1.25

Inflammatory chemokines in cancer growth and progression. Eur J Cancer (2006) 1.18

C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol (2007) 1.17

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol (1999) 1.15

Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res (1991) 1.14

C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr (2003) 1.14

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J (2005) 1.08

High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer Res (2009) 1.06

Vitamin C deficiency in cancer patients. Palliat Med (2005) 1.05

Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms. Curr Prostate Rep (2008) 1.02

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer (2001) 1.02

Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res (2001) 1.01

High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn J Cancer Res (1994) 1.00

Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy. Integr Cancer Ther (2002) 0.98

Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology (2001) 0.96

Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J (2008) 0.95

Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med (2008) 0.92

Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine (2004) 0.90

Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res (2010) 0.88

Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells. Biochem J (1997) 0.83

C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. Biomark Insights (2007) 0.83

CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity (2007) 0.82

Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J (2005) 0.82

Oxidative stress is involved in the heat stress-induced downregulation of TCR zeta chain expression and TCR/CD3-mediated [Ca(2+)](i) response in human T-lymphocytes. Cell Immunol (2002) 0.82

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk. Br J Cancer (2009) 0.81

Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer. Ann Pharmacother (2007) 0.80

Chemokines and cancer. Cancer Treat Res (2005) 0.79

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66

Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45

Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int (2005) 2.29

Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation (2004) 2.28

Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19

Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc (2004) 1.85

Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76

Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology (2005) 1.63

Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A (2005) 1.57

Mechanism of Mos1 transposition: insights from structural analysis. EMBO J (2006) 1.48

Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol (2006) 1.47

Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". Cell (2011) 1.34

Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial. J Thorac Oncol (2013) 1.17

S-nitrosylation of AtSABP3 antagonizes the expression of plant immunity. J Biol Chem (2008) 1.16

Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J (2005) 1.14

A structure-based mutational analysis of cyclophilin 40 identifies key residues in the core tetratricopeptide repeat domain that mediate binding to Hsp90. J Biol Chem (2002) 1.13

Visuomotor priming by pictures of hand postures: perspective matters. Neuropsychologia (2003) 1.12

Octaheme tetrathionate reductase is a respiratory enzyme with novel heme ligation. Nat Struct Mol Biol (2004) 1.10

Multi-intervention management of calciphylaxis: a report of 7 cases. Am J Kidney Dis (2011) 1.08

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J (2005) 1.08

Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics (2009) 1.07

Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem (2002) 1.04

Expression, purification and preliminary crystallographic studies of a single-point mutant of Mos1 mariner transposase. Acta Crystallogr D Biol Crystallogr (2004) 1.03

A systematic review of computer-assisted diagnosis in diagnostic cancer imaging. Eur J Radiol (2011) 1.02

Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue. Clin Proteomics (2012) 1.01

Making decisions about mammography. BMJ (2005) 0.99

Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry. J Proteome Res (2010) 0.99

Structures of immunophilins and their ligand complexes. Curr Top Med Chem (2003) 0.98

Crystal structure of a thermostable lipase from Bacillus stearothermophilus P1. J Mol Biol (2002) 0.98

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clin Cancer Res (2010) 0.97

Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure (2003) 0.96

Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J (2003) 0.96

EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res (2010) 0.96

Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition. Proc Natl Acad Sci U S A (2009) 0.96

Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor. J Biol Chem (2013) 0.92

Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res (2008) 0.91

nemy encodes a cytochrome b561 that is required for Drosophila learning and memory. Proc Natl Acad Sci U S A (2008) 0.91

Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb. Mol Cell Proteomics (2012) 0.91

Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res (2010) 0.91

Emerging applications for phospho-proteomics in cancer molecular therapeutics. Biochim Biophys Acta (2006) 0.91

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med (2013) 0.90

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial. Lung Cancer (2011) 0.88

Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun (2010) 0.88

Distinct properties of murine alpha 5 gamma-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy. J Neurosci Res (2009) 0.88

Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? Clin Chem (2012) 0.87

The effects of the odstock drop foot stimulator on perceived quality of life for people with stroke and multiple sclerosis. Neuromodulation (2010) 0.86

Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS One (2013) 0.86

Identification of protein binding surfaces using surface triplet propensities. Bioinformatics (2010) 0.86

Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle (2009) 0.85

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Lung Cancer (2011) 0.85

Accelerometer-triggered electrical stimulation for reach and grasp in chronic stroke patients: a pilot study. Neurorehabil Neural Repair (2011) 0.85

A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol (2010) 0.85

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.84

Atypical (RIO) protein kinases from Haemonchus contortus--promise as new targets for nematocidal drugs. Biotechnol Adv (2011) 0.84

The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Proteomics (2014) 0.83

Long C terminal splice variant CaV2.2 identified in presynaptic membrane by mass spectrometric analysis. Channels (Austin) (2010) 0.82

Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients. Am J Kidney Dis (2003) 0.82

Vascular access planning in peritoneal dialysis patients. Perit Dial Int (2008) 0.82

Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics (2014) 0.81

A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry. Mol Cell Proteomics (2014) 0.81

Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices. Nephrol Dial Transplant (2012) 0.81

Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer. J Proteome Res (2011) 0.81

Expression, purification, crystallization and preliminary crystallographic analysis of a thermostable lipase from Bacillus stearothermophilus P1. Acta Crystallogr D Biol Crystallogr (2001) 0.81

Identification of paediatric tuberculosis from airway shape features. Med Image Comput Comput Assist Interv (2011) 0.80

Analytical and preparative instrumentation. J Biomol Screen (2013) 0.80

Caldicott 2 and patient data. BMJ (2013) 0.80

Towards rational approaches of health care utilization in complex patients: an exploratory randomized trial comparing a novel combined clinic to multiple specialty clinics in patients with renal disease-cardiovascular disease-diabetes. Nephrol Dial Transplant (2011) 0.80

Evaluation of PROforma as a language for implementing medical guidelines in a practical context. BMC Med Inform Decis Mak (2006) 0.80

Vascular stiffness in incident peritoneal dialysis patients over time. Clin Nephrol (2012) 0.79

Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG (2005) 0.79

Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms. Mol Cell Proteomics (2012) 0.79

Adenosquamous carcinoma of the lung diagnosed by cytology?: a diagnostic dilemma. Diagn Cytopathol (2011) 0.79

Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in Caenorhabditis elegans. Biochem Biophys Res Commun (2007) 0.79

An implantable two channel drop foot stimulator: initial clinical results. Artif Organs (2002) 0.79

Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone. J Biomed Biotechnol (2003) 0.79

Selective chemical intervention in the proteome of Caenorhabditis elegans. J Proteome Res (2010) 0.77

Structural and biological characterisation of the gut-associated cyclophilin B isoforms from Caenorhabditis elegans. J Mol Biol (2002) 0.77

Construction of an odds model of coronary heart disease using published information: the Cardiovascular Health Improvement Model (CHIME). BMC Med Inform Decis Mak (2008) 0.77

The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission. Altern Ther Health Med (2012) 0.77

Recommendations for research design and reporting in computer-assisted diagnosis to facilitate meta-analysis. J Biomed Inform (2011) 0.77

Comprehensive identification of phosphorylation sites on the Numb endocytic adaptor protein. Proteomics (2015) 0.77

The First Direct Determination of a Ligand Binding Constant in Protein Crystals. Angew Chem Int Ed Engl (2001) 0.77

A randomised controlled trial of integrated electrical stimulation and physiotherapy to improve mobility for people less than 6 months post stroke. Disabil Rehabil Assist Technol (2014) 0.77

emc has a role in dorsal appendage fate formation in Drosophila oogenesis. Mech Dev (2005) 0.77

Skeletal and dental outcomes of a new magnetic functional appliance, the Sydney Magnoglide, in Class II correction. Am J Orthod Dentofacial Orthop (2012) 0.77

Implicit alcohol-aggression scripts and alcohol-related aggression on a laboratory task in 11- to 14-year-old adolescents. Aggress Behav (2011) 0.77

Effect of atenolol on aldosterone/renin ratio calculated by both plasma Renin activity and direct Renin concentration in healthy male volunteers. J Clin Endocrinol Metab (2010) 0.77

The effect of glycaemic index of high carbohydrate diets consumed over 5 days on exercise energy metabolism and running capacity in males. J Sports Sci (2009) 0.76

Incidental atherosclerotic renal artery stenosis diagnosed at cardiac catheterization: no difference in kidney function with or without stenting. Am J Nephrol (2008) 0.76

Differential regulation of FGFR3 by PTPN1 and PTPN2. Proteomics (2014) 0.76

Underestimating the impact of ventilator-associated pneumonia by use of surveillance data. Infect Control Hosp Epidemiol (2010) 0.76

Purification of protein C from canine plasma. BMC Vet Res (2014) 0.75

Renal transplant imaging and complications. Abdom Imaging (2007) 0.75

A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines. Curr Drug Discov Technol (2013) 0.75

Training and orthotic effects related to functional electrical stimulation of the peroneal nerve in stroke. J Rehabil Med (2017) 0.75

The well-being of young adults in the "Next America". Am J Orthopsychiatry (2015) 0.75

Elimination of BNP by peritoneal dialysis: investigation of analytical issues. Perit Dial Int (2011) 0.75

Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes. Acta Crystallogr D Biol Crystallogr (2004) 0.75